Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion

International Journal of Oncology - Tập 48 Số 4 - Trang 1639-1649 - 2016
Linlin Li1, Lei Dong2, Xiaotong Qu3, Shi Jin2, Xiupeng Lv4, Guang Tan5
1The 4th Medical Department of Liaoning Cancer Hospital and Institute, Dadong District, Shenyang, Liaoning 110042, P.R. China
2Department of Laparoscopic Surgery, First Affiliated Hospital of Dalian Medical University, Shahekou District, Dalian, Liaoning 116001, P.R. China
3Department of Second Neurology, The First Affiliated Hospital of Dalian Medical University, Xigang District, Dalian, Liaoning 116000, P.R. China
4Department of Radiation Oncology, First Affiliated Hospital of Dalian Medical University, Shahekou District, Dalian, Liaoning 116001, P.R. China
5Department of Hepatology, First Affiliated Hospital of Dalian Medical University, Shahekou District, Dalian, Liaoning 116001, P.R. China

Tóm tắt

Từ khóa


Tài liệu tham khảo

DeSantis, 2014, Cancer treatment and survivorship statistics, 2014, CA Cancer J Clin, 64, 252, 10.3322/caac.21235

Siegel, 2014, Cancer statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208

Hato, 2014, Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions, Hepatology, 60, 1776, 10.1002/hep.27246

El-Serag, 2014, Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?, Hepatology, 60, 1767, 10.1002/hep.27222

Marshall, 2010, TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells, Oncogene, 29, 6172, 10.1038/onc.2010.340

Bell, 2012, TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members, PLoS One, 7, e37470, 10.1371/journal.pone.0037470

Sutton, 2014, TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells, Oncotarget, 5, 10127, 10.18632/oncotarget.2466

Cheung, 2012, The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro, J Pathol, 226, 451, 10.1002/path.2986

You, 2010, Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta, Hepatology, 51, 1635, 10.1002/hep.23544

Wang, 2014, CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression, Cancer Res, 74, 520, 10.1158/0008-5472.CAN-13-2182

Wang, 2014, CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR, Mol Cancer, 13, 252, 10.1186/1476-4598-13-252

Sun, 2014, Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation, Mol Cancer, 13, 137, 10.1186/1476-4598-13-137

Thiery, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007

Floor, 2011, Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: Distinct, overlapping or same populations, Oncogene, 30, 4609, 10.1038/onc.2011.184

Hills, 2011, The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy, Cytokine Growth Factor Rev, 22, 131

Yilmaz, 2009, EMT, the cytoskeleton, and cancer cell invasion, Cancer Metastasis Rev, 28, 15, 10.1007/s10555-008-9169-0

Huo, 2015, Tripartite motif 16 inhibits epithelial-mesenchymal transition and metastasis by down-regulating sonic hedgehog pathway in non-small cell lung cancer cells, Biochem Biophys Res Commun, 460, 1021, 10.1016/j.bbrc.2015.03.144

van Zijl, 2009, Epithelial-mesenchymal transition in hepatocellular carcinoma, Future Oncol, 5, 1169, 10.2217/fon.09.91